Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
Siriruk Changrob, Peter Halfmann, Hejun Liu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 8
Open Access | Times Cited: 12

Showing 12 citing articles:

The presence of broadly neutralizing anti-SARS-CoV-2 RBD antibodies elicited by primary series and booster dose of COVID-19 vaccine
Xiaorui Chen, Arpita Mohapatra, Hong Thuy Vy Nguyen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012246-e1012246
Open Access | Times Cited: 2
Ultrapotent class I neutralizing antibodies post Omicron breakthrough infection overcome broad SARS-CoV-2 escape variants
Mengxiao Luo, Runhong Zhou, Bingjie Tang, et al.
EBioMedicine (2024) Vol. 108, pp. 105354-105354
Open Access | Times Cited: 2
Rapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including BQ.1.1, CA.3.1, CH.1.1, XBB.1.16, and XBB.1.5
Kevin C. Entzminger, Jonathan K. Fleming, Paul D. Entzminger, et al.
Antibody Therapeutics (2023) Vol. 6, Iss. 2, pp. 108-118
Open Access | Times Cited: 7
Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1
Jiali Wang, Bingjie Shi, Hanyi Chen, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 417-417
Open Access | Times Cited: 1
Impact of COVID‐19 monoclonal antibodies on outcomes of COVID‐19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients
E Hahn, Hong Li, Craig S. Sauter, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 4
Open Access | Times Cited: 1
Anti-SARS-CoV-2 serology based on ancestral RBD antigens does not correlate with the presence of neutralizing antibodies against Omicron variants
Léa Dépéry, Isabelle Bally, Axelle Amen, et al.
Microbiology Spectrum (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Excess Mortality in Kidney and Kidney-Pancreas Transplant Recipients in the COVID-19 Pandemic in Portugal—A Cohort Study
Miguel Coimbra, José A. T. S. Francisco, Joana C. Freitas, et al.
Transplant International (2023) Vol. 36
Open Access | Times Cited: 2
Mutability and hypermutation antagonize immunoglobulin codon optimality
Joshua J.C. McGrath, Juyeon Park, Chloe Troxell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Coronavirus Disease 2019 in Kidney Transplantation – A 2024 Update
Bassam G. Abu Jawdeh, Holenarasipur R. Vikram
Advances in Kidney Disease and Health (2024) Vol. 31, Iss. 5, pp. 458-465
Closed Access
Mutability and hypermutation antagonize immunoglobulin codon optimality
Joshua J.C. McGrath, Juyeon Park, Chloe Troxell, et al.
Molecular Cell (2024) Vol. 85, Iss. 2, pp. 430-444.e6
Closed Access
Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents
Masaru Takeshita, Hidehiro Fukuyama, Katsuhiko Kamada, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106955-106955
Open Access | Times Cited: 1
Does the SARS-CoV-2 spike really have an Achilles heel?
Shiv Pillai
Journal of Clinical Investigation (2023) Vol. 133, Iss. 8
Open Access
Page 1

Scroll to top